ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1973

Work-related Impact in Young Patients with Chronic Back Pain Awaiting a Magnetic Resonance Imaging

Diego Benavent1, Mar Tapia2, Daniel Bernabeu2, Victor muley2, Chamaida Plasencia-Rodríguez3, Alejandro Balsa3 and Victoria Navarro-Compán4, 1Hospital la Paz, Madrid, Spain, 2Radiology Department, Hospital La Paz, Madrid, Spain, 3Hospital Universitario La Paz, Madrid, Spain, 4Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain

Meeting: ACR Convergence 2023

Keywords: Back pain, Outcome measures, work

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1973–1976) Orthopedics, Low Back Pain, & Rehabilitation Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Chronic back pain (CBP) is one of the major causes for medical consultation among young people. Given the limited sources, it is relevant knowing the characteristics associated with a higher burden in order to prioritize the performance of imaging exams. We aimed to identify factors associated with sick leave in a cohort of young patients with CBP awaiting an MRI of the spine.

Methods: The project “Strategy for a Hospital Early Referral in Patients with Axial Spondyloarthritis” (SHERPAS) is a prospective ongoing study recruiting young patients (18 to 40 years) with CBP that are requested an MRI of the spine by other specialists different than rheumatologists in a tertiary hospital. The study period started in September 2021, and the dataset for this interim analysis was locked in October 2022. Patients completed a questionnaire concerning work status, including sick leave due to CBP (at-visit or prior to this). Besides, socio-demographic and clinical characteristics were collected. Patient-reported outcomes (PROs) for fatigue, Patient Global Assessment (PGA), physical function (Bath Ankylosing Spondylitis Functional Index -BASFI), and overall health (Assessment of Spondyloarthritis international Society Health Index -ASAS HI) were also evaluated. A logistic regression analysis was performed to evaluate the association of patients’ characteristics with sick leave.

Results: Of 152 recruited patients, 123 (80.9%) were actively employed, 22 (14.5%) were unemployed and 7 (4.6%) were students. Among the employed patients (52.8% female; mean age 33.8(4.8) years; 57.0 (54.0) months CBP duration), 65 (52.8%) patients had been on sick leave at some point (50 prior to visit and 15 at the study visit). Baseline characteristics are shown in Table. Night pain was more frequent in patients on sick leave (56.9 % vs 36.2%, p=0.02), and PROs on fatigue, PGA, physical function and overall health and functioning showed worse results in these patients, as compared to patients who had never been in sick leave. Additionally, patients with on sick leave had more frequently pharmacological treatment. After multivariable analysis, being male (OR 2.3, 95%CI 1.0-5.6), having night pain (OR=2.4, 95%CI 1.0-5.8) and reporting higher PGA (OR=1.1, 95%CI 1.0-1.4) were associated independently with being on sick leave.

Conclusion: One out of two young patients with CBP awaiting an MRI of the spine are on sick leave at some point. These patients have poorer quality of life and use more pharmacological treatment than active patients with CBP. Male sex and night pain are associated with being on sick leave due to CBP and therefore could be used to prioritize the use of spinal MRI aiming to optimize health resources.

Supporting image 1

Table. Characteristics of employed patients by work status


Disclosures: D. Benavent: Abbvie, 5, Galapagos, 6, Janssen, 6, Novartis, 5, Roche, 6; M. Tapia: None; D. Bernabeu: None; V. muley: None; C. Plasencia-Rodríguez: Abbvie, 5, 6, Eli Lilly, 6, Novartis, 5, Pfizer, 5, 6, Roche, 6; A. Balsa: AbbVie/Abbott, 1, 2, 5, 6, Bristol-Myers Squibb(BMS), 1, 5, Eli Lilly, 1, 5, 6, Merck/MSD, 1, 5, Novartis, 5, Pfizer, 1, 5, 6, UCB, 1, 5, 6; V. Navarro-Compán: AbbVie, 2, 5, 6, Eli Lilly, 2, 6, Galapagos, 2, Janssen, 6, MoonLake, 2, MSD, 2, 6, Novartis, 2, 5, 6, Pfizer, 2, 6, UCB, 2, 6.

To cite this abstract in AMA style:

Benavent D, Tapia M, Bernabeu D, muley V, Plasencia-Rodríguez C, Balsa A, Navarro-Compán V. Work-related Impact in Young Patients with Chronic Back Pain Awaiting a Magnetic Resonance Imaging [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/work-related-impact-in-young-patients-with-chronic-back-pain-awaiting-a-magnetic-resonance-imaging/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/work-related-impact-in-young-patients-with-chronic-back-pain-awaiting-a-magnetic-resonance-imaging/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology